688065 Stock Overview
A bio-manufacturing technology company, researches, develops, produces, and sells bio-based materials in China and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 1/6 |
Cathay Biotech Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥38.08 |
52 Week High | CN¥56.80 |
52 Week Low | CN¥32.48 |
Beta | 0.47 |
11 Month Change | 9.49% |
3 Month Change | -16.10% |
1 Year Change | -31.41% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -37.77% |
Recent News & Updates
Recent updates
Shareholder Returns
688065 | CN Chemicals | CN Market | |
---|---|---|---|
7D | 15.4% | 15.3% | 15.4% |
1Y | -31.4% | -15.8% | -7.9% |
Return vs Industry: 688065 underperformed the CN Chemicals industry which returned -20.1% over the past year.
Return vs Market: 688065 underperformed the CN Market which returned -12.3% over the past year.
Price Volatility
688065 volatility | |
---|---|
688065 Average Weekly Movement | 5.1% |
Chemicals Industry Average Movement | 5.1% |
Market Average Movement | 5.6% |
10% most volatile stocks in CN Market | 8.5% |
10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 688065 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688065's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 1,803 | Xiucai Liu | www.cathaybiotech.com |
Cathay Biotech Inc., a bio-manufacturing technology company, researches, develops, produces, and sells bio-based materials in China and internationally. It offers biological long-chain diacids comprising sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine. The products are used in various applications, including textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, and other industries.
Cathay Biotech Inc. Fundamentals Summary
688065 fundamental statistics | |
---|---|
Market cap | CN¥23.66b |
Earnings (TTM) | CN¥372.11m |
Revenue (TTM) | CN¥2.53b |
63.6x
P/E Ratio9.4x
P/S RatioIs 688065 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688065 income statement (TTM) | |
---|---|
Revenue | CN¥2.53b |
Cost of Revenue | CN¥1.81b |
Gross Profit | CN¥713.75m |
Other Expenses | CN¥341.63m |
Earnings | CN¥372.11m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.64 |
Gross Margin | 28.23% |
Net Profit Margin | 14.72% |
Debt/Equity Ratio | 8.8% |
How did 688065 perform over the long term?
See historical performance and comparison